A detailed history of Fountainhead Am, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fountainhead Am, LLC holds 651 shares of LLY stock, worth $541,332. This represents 0.13% of its overall portfolio holdings.

Number of Shares
651
Previous 691 5.79%
Holding current value
$541,332
Previous $625,000 7.84%
% of portfolio
0.13%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $30,885 - $38,400
-40 Reduced 5.79%
651 $576,000
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $500,885 - $628,146
691 New
691 $625,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $790B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fountainhead Am, LLC Portfolio

Follow Fountainhead Am, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fountainhead Am, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fountainhead Am, LLC with notifications on news.